Mirum Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 6.80 M | $536.75 M | 0.00% | 11.70% |
| BLACKROCK, INC. | 02/12/2026 | 3.65 M | $287.94 M | 1.19% | 6.27% |
| VANGUARD GROUP INC | 01/29/2026 | 2.60 M | $205.07 M | 1.99% | 4.47% |
| STATE STREET CORP | 02/13/2026 | 2.14 M | $169.35 M | 59.18% | 3.69% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 2.09 M | $165.37 M | -17.01% | 3.60% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.06 M | $83.98 M | 5.24% | 1.83% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 865.97 K | $68.40 M | -13.73% | 1.49% |
| CITADEL ADVISORS LLC | 02/17/2026 | 840.22 K | $66.37 M | -19.25% | 1.45% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 724.32 K | $57.21 M | 60.66% | 1.25% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 655.78 K | $51.80 M | 9.10% | 1.13% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 650.72 K | $51.40 M | 8.25% | 1.12% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 579.98 K | $45.81 M | -12.38% | 1.00% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 577.27 K | $45.60 M | 6.65% | 0.99% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 573.61 K | $45.31 M | 285.76% | 0.99% |
| CANDRIAM S.C.A. | 02/13/2026 | 569.59 K | $44.99 M | 41.33% | 0.98% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 565.58 K | $44.68 M | 26.95% | 0.97% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 521.65 K | $41.21 M | 5.18% | 0.90% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 514.98 K | $40.68 M | -4.46% | 0.89% |
| NUVEEN, LLC | 02/12/2026 | 503.05 K | $39.74 M | -16.39% | 0.87% |
| FEDERATED HERMES, INC. | 02/12/2026 | 481.96 K | $38.07 M | 39.09% | 0.83% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 481.56 K | $38.04 M | -15.60% | 0.83% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 439.09 K | $34.68 M | -14.48% | 0.76% |
| MORGAN STANLEY | 02/13/2026 | 425.69 K | $33.62 M | -36.48% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 409.29 K | $32.33 M | 3.75% | 0.70% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/06/2026 | 395.83 K | $31.27 M | 31.66% | 0.68% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 372.51 K | $29.42 M | -39.16% | 0.64% |
| NEXT CENTURY GROWTH INVESTORS LLC | 02/13/2026 | 368.04 K | $29.07 M | 1.97% | 0.63% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 367.13 K | $29.00 M | -0.67% | 0.63% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 02/09/2026 | 336.70 K | $26.60 M | 7.48% | 0.58% |
| UBS GROUP AG | 01/29/2026 | 320.78 K | $25.34 M | 16.29% | 0.55% |
| PATIENT SQUARE CAPITAL LP | 02/12/2026 | 298.68 K | $23.59 M | 186.47% | 0.51% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/09/2026 | 281.92 K | $22.32 M | -8.47% | 0.49% |
| NORGES BANK | 02/10/2026 | 263.18 K | $20.79 M | 100.00% | 0.45% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 257.23 K | $20.32 M | 100.00% | 0.44% |
| ERSTE ASSET MANAGEMENT GMBH | 02/11/2026 | 250.00 K | $19.78 M | 0.00% | 0.43% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 246.42 K | $19.46 M | -2.11% | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/09/2026 | 242.32 K | $19.14 M | 10.63% | 0.42% |
| NAN FUNG TRINITY (HK) LTD | 02/04/2026 | 227.48 K | $17.97 M | 45.57% | 0.39% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 225.00 K | $17.77 M | 100.00% | 0.39% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 217.61 K | $17.19 M | -10.59% | 0.37% |
| HANDELSBANKEN FONDER AB | 02/06/2026 | 213.50 K | $16.86 M | 100.00% | 0.37% |
| NICHOLAS INVESTMENT PARTNERS, LP | 02/13/2026 | 213.39 K | $16.86 M | -1.69% | 0.37% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 186.71 K | $14.75 M | 1.29% | 0.32% |
| SEGALL BRYANT & HAMILL, LLC | 02/13/2026 | 185.02 K | $14.62 M | 100.00% | 0.32% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 172.43 K | $13.62 M | 34.81% | 0.30% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 168.39 K | $13.30 M | 0.70% | 0.29% |
| CITIGROUP INC | 02/13/2026 | 145.99 K | $11.53 M | -0.86% | 0.25% |
| BARCLAYS PLC | 02/13/2026 | 142.14 K | $11.23 M | 22.78% | 0.24% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 137.70 K | $10.88 M | -4.54% | 0.24% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 133.97 K | $10.58 M | 0.00% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mirum Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 278 institutional investors and hedge funds held shares of Mirum Pharmaceuticals Inc. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 6.8 M
BlackRock, Inc.: 3.65 M
VANGUARD GROUP INC: 2.6 M
STATE STREET CORP: 2.14 M
EVENTIDE ASSET MANAGEMENT, LLC: 2.09 M
GEODE CAPITAL MANAGEMENT, LLC: 1.06 M
77.50% of Mirum Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 43.02 M shares in the last 24 months. This purchase volume represents approximately $4.42 B in transactions.